GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (STU:82F) » Definitions » EPS (Diluted)

NFL Biosciences (STU:82F) EPS (Diluted) : €-0.48 (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences EPS (Diluted)?

NFL Biosciences's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was €-0.20. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.48.

NFL Biosciences's EPS (Basic) for the six months ended in Dec. 2023 was €-0.20. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.48.

NFL Biosciences's EPS without NRI for the six months ended in Dec. 2023 was €-0.20. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.48.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


NFL Biosciences EPS (Diluted) Historical Data

The historical data trend for NFL Biosciences's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences EPS (Diluted) Chart

NFL Biosciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial -0.05 -0.05 -0.19 -0.47 -0.46

NFL Biosciences Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
EPS (Diluted) Get a 7-Day Free Trial -0.19 -0.21 -0.26 -0.28 -0.20

Competitive Comparison of NFL Biosciences's EPS (Diluted)

For the Biotechnology subindustry, NFL Biosciences's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NFL Biosciences's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NFL Biosciences's PE Ratio distribution charts can be found below:

* The bar in red indicates where NFL Biosciences's PE Ratio falls into.



NFL Biosciences EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

NFL Biosciences's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-3.745-0)/8.107
=-0.46

NFL Biosciences's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.635-0)/8.107
=-0.20

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NFL Biosciences  (STU:82F) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


NFL Biosciences EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of NFL Biosciences's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


NFL Biosciences (STU:82F) Business Description

Traded in Other Exchanges
Address
199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences (STU:82F) Headlines

No Headlines